The Environment Consultant

GlaxoSmithKline (GSK), the global pharmaceutical company, has undertaken a coordinated approach to manage and disclose nature-related risks by implementing both the Science Based Targets Network (SBTN) and the Taskforce on Nature-related Financial Disclosures (TNFD) frameworks.

This integration aims to ensure that corporate operations, supply chain decisions, and financial reporting reflect ecological thresholds while aligning with enterprise risk management and stakeholder expectations.

Assessment and Prioritisation

GSK began by assessing its dependencies and impacts on nature through the SBTN methodology. The company conducted spatial mapping of its global manufacturing sites and upstream suppliers to identify regions where its water use, land footprint, and ecosystem impacts were material.

The Upper Godavari basin in India emerged as a priority due to high water stress and intensive industrial activity. SBTN analysis quantified site-level freshwater withdrawals relative to ecological limits and assessed land-use impacts, providing location-specific thresholds for sustainable operations.

Concurrently, GSK applied the TNFD framework to translate ecological exposures into financial and strategic implications. Using TNFD’s Locate and Assess guidance, the company identified sites and suppliers whose ecosystem dependencies could pose operational, regulatory, or reputational risks.

TNFD analysis extended beyond ecological metrics to evaluate potential impacts on enterprise value, capital planning, and long-term operational resilience. This dual assessment created a unified understanding of where ecological risks intersect with financial materiality.

Target Setting and Scenario Analysis

Under SBTN, GSK established science-based freshwater targets for its Nashik manufacturing site in India, specifying absolute reductions in withdrawals and improvements in wastewater treatment to remain within basin-level ecological thresholds.

Land-related targets included minimizing conversion of natural habitats and engaging in restoration initiatives in priority sourcing regions. These targets were operationalized through process optimization, supplier engagement, and capital allocation for sustainable interventions.

The TNFD framework complemented this by requiring financially oriented scenario analysis. GSK modeled potential impacts of water scarcity, regulatory changes, and reputational pressures under alternative future scenarios.

This forward-looking assessment helped translate ecological thresholds into financial risk exposure, guiding strategic decision-making and linking operational targets to enterprise risk management.

Scenario results informed investment prioritization, including infrastructure upgrades, supply chain interventions, and mitigation strategies aligned with both SBTN targets and TNFD financial considerations.

Governance, Integration, and Reporting

Integration of SBTN and TNFD was embedded into governance structures. Corporate sustainability, operations, and finance teams coordinated to monitor progress on both ecological targets and nature-related financial risks.

Key indicators included site-level water withdrawals relative to sustainable limits, supplier adherence to ecological thresholds, exposure of operations to high-risk basins, and projected financial impact of nature-related disruptions.

For external reporting, SBTN targets provided measurable, science-aligned outcomes, while TNFD disclosures communicated the financial materiality of GSK’s nature-related risks.

Together, these frameworks allowed GSK to present a transparent, decision-useful view of both ecological performance and associated financial implications, demonstrating how mitigation actions reduce exposure to operational and investment risks.

Operational Implementation

At the Nashik site, operational measures included reducing freshwater withdrawals through process efficiency improvements, implementing advanced wastewater treatment, and engaging upstream suppliers on water stewardship practices.

Across other high-risk sites and sourcing regions, GSK applied SBTN-based restoration and land-use interventions while using TNFD-aligned risk assessment to prioritize investments and capital allocation where nature-related risks posed the greatest potential financial impact.

Insights and Strategic Value

The combined approach demonstrated the synergy between science-based ecological targets and nature-related financial disclosure. SBTN provided quantifiable, location-specific ecological targets, while TNFD ensured these targets were contextualized within corporate financial risk and strategic decision-making. The integrated framework allowed GSK to anticipate risks, allocate resources efficiently, and enhance transparency to investors, regulators, and stakeholders.

While challenges remain, including data gaps in supplier operations and evolving regulatory expectations, the dual implementation of SBTN and TNFD at GSK represents a structured, forward-looking pathway for embedding nature considerations into both operational management and corporate financial governance.